The Italian Competition Authority fines a pharmaceutical group over generics (Pfizer)

On 17 January 2012, the Italian Competition Authority (“Autorità Garante della Concorrenza e del Mercato”) announced that it had fined pharmaceutical group Pfizer € 10.6 million for abuse of dominance in the market for

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Van Bael & Bellis (Brussels)

Quotation

Peter L'Ecluse, The Italian Competition Authority fines a pharmaceutical group over generics (Pfizer), 11 January 2012, e-Competitions January 2012, Art. N° 58841

Visites 242

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues